Michael Polansky Is Training an AI Model on Living Human Skin

Michael Polansky may be best known to the public as Lady Gaga's partner, but behind the scenes he has spent years quietly building a biotechnology venture that blends artificial intelligence with cutting-edge tissue science. The startup has been operating largely under the radar, and only now is stepping into the public spotlight with its groundbreaking approach to skincare research.

At the heart of the company's technology is a proprietary method for keeping living human skin tissue alive outside the body for weeks at a time. This platform allows researchers to test thousands of chemical compounds directly on living skin cells, providing a level of biological accuracy that far exceeds what is possible through traditional lab tests, computer simulations, or animal trials. The result is a richer, more realistic dataset for the AI to learn from.

The AI model trained on this data can identify complex patterns and predict which compounds are most likely to produce effective, safe skincare products. Polansky, who previously served as a top deputy to Sean Parker — the Napster co-founder and early Facebook investor — has leveraged his deep ties to the tech world to bring a startup mentality and venture capital acumen to an industry historically slow to embrace scientific innovation.

By going public now, the company appears ready to scale its research efforts, attract new investment, and potentially partner with major players in the beauty and pharmaceutical industries. The announcement raises important questions not only about the future of AI-driven skincare, but also about the ethical considerations surrounding the commercial use of living human tissue in product development.